Your browser doesn't support javascript.
Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres.
Gottlieb, Jens; Kolditz, Martin; Gade, Nils; Welte, Tobias; Kneidinger, Nikolaus.
  • Gottlieb J; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany gottlieb.jens@mh-hannover.de.
  • Kolditz M; Both authors contributed equally.
  • Gade N; Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Welte T; Both authors contributed equally.
  • Kneidinger N; Department of Internal Medicine I, University Hospital, LMU Munich, Germany.
Eur Respir J ; 60(1)2022 07.
Article in English | MEDLINE | ID: covidwho-2029682
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Transplantation / COVID-19 / Antibodies, Monoclonal Type of study: Observational study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.00124-2022

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Transplantation / COVID-19 / Antibodies, Monoclonal Type of study: Observational study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.00124-2022